Erlotinib in metastatic pulmonary adenocarcinomas harbouring EGFR activating mutations, in Sao Paulo - Brazil
Rafael Caires-Lima Bruno M Protasio; Tiago K Takahashi; Milena P Mak; Denyei Nakazato; Cristiane S Mesquita; Teresa Y Takagaki; Iberê C Soares; Evandro S Mello; Paulo M Hoff; Venâncio A Alves; Gilberto Castro Jr.; World Conference on Lung Cancer (15. 2013 Sydney)
Journal of thoracic oncology Hagerstown v. 8, suppl. 2, p. S892, res. P2.11-009, 20132013
Localização: FM - Fac. Medicina (BCSEP 558 2013 )(Acessar)